Form 4 for CSTL CASTLE BIOSCIENCES INC
Accepted 2022-01-20 00:00:00 ET · period of report 2022-01-10 · accession 0001447362-22-000018 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| I | 2022-01-20 | 2022-01-10 | CSTL | MAETZOLD DEREK J | Pres, Chief Exec. Off, Dir | G - Gift | $0.00 | -122.2K | 0 | -100% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2022-01-10 | G | D | 122,181 | $0.00 | 0 | I By DJM Grantor Retained Annuity Trust No. 1 | — | — | (F1) On January 5, 2022, the Reporting Person transferred 5,547 shares of Castle Biosciences, Inc. common stock to his direct holdings. (F2) On January 10, 2022, the Reporting Person transferred 122,181 shares collectively of Castle Biosciences, Inc. common stock to The Maetzold 2018 Remainder Trust FBO Hannah Elizabeth Maetzold, The Maetzold 2018 Remainder Trust FBO Peter Douglas Maetzold, The Maetzold 2018 Remainder Trust FBO Emily Carol Kirk, and The Maetzold 2018 Remainder Trust FBO John Derek Maetzold, all of which the Reporting Person is the trustee and his children are the beneficiaries. |